4//SEC Filing
MAIN ALAN J 4
Accession 0001127602-25-007534
CIK 0001062822other
Filed
Mar 2, 7:00 PM ET
Accepted
Mar 3, 4:32 PM ET
Size
15.5 KB
Accession
0001127602-25-007534
Insider Transaction Report
Form 4
MAIN ALAN J
EVP, Pharmaceutical Research
Transactions
- Exercise/Conversion
Common Stock
2025-02-28+25,667→ 281,391 total - Exercise/Conversion
Common Stock
2025-02-28+68,243→ 382,538 total - Tax Payment
Common Stock
2025-02-28$0.67/sh−43,434$29,101→ 339,104 total - Exercise/Conversion
Restricted Stock Units
2025-02-28−25,667→ 0 total→ Common Stock (25,667 underlying) - Exercise/Conversion
Common Stock
2025-02-28+32,904→ 314,295 total - Exercise/Conversion
Restricted Stock Units
2025-02-28−32,904→ 32,903 total→ Common Stock (32,904 underlying) - Exercise/Conversion
Restricted Stock Units
2025-02-28−68,243→ 136,487 total→ Common Stock (68,243 underlying)
Footnotes (3)
- [F1]Each restricted stock unit represents a contingent right to receive one share of common stock.
- [F2]Withholding of a portion of issued shares by the Company in satisfaction of shareholder's tax withholding obligations with respect thereto.
- [F3]Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant.
Documents
Issuer
LEXICON PHARMACEUTICALS, INC.
CIK 0001062822
Entity typeother
Related Parties
1- filerCIK 0001227372
Filing Metadata
- Form type
- 4
- Filed
- Mar 2, 7:00 PM ET
- Accepted
- Mar 3, 4:32 PM ET
- Size
- 15.5 KB